Intelligent Ultrasound Group PLC Directorate Change (7818L)
15 Septembre 2021 - 8:00AM
UK Regulatory
TIDMIUG
RNS Number : 7818L
Intelligent Ultrasound Group PLC
15 September 2021
15 September 2021
Intelligent Ultrasound Group plc
("IUG" or the "Company" or the "Group")
Directorate Change
Appointment of Michele Lesieur to Board
Intelligent Ultrasound Group plc (AIM: IUG), the ultrasound
artificial intelligence (AI) software and simulation company,
announces that Michele Lesieur will be joining the Board as a
Non-executive Director with effect from 20 September 2021.
Michele brings to the Company outstanding industry, corporate
governance, and investor relations experience, having been CEO of
Philips France and General Manager of Philips Healthcare France and
most recently CEO of Euronext listed Supersonic Imagine, that was
sold to Hologic in 2019 and Non-executive Director of EOS Imaging,
a listed software medtech company, sold to Nasdaq listed Alphatec
Holdings, Inc in 2021.
Michele remains Chairman of the Board of Intrasense, a listed
software medtech company and Non-executive Director of Prodways
Group, a listed 3D printing company.
Riccardo Pigliucci, Chairman of Intelligent Ultrasounds Group
plc said : "I am delighted that Michele has chosen to join
Intelligent Ultrasound as a Non-executive Director. She was an
exceptional candidate for the position, with outstanding commercial
experience in the medical imaging sector and her wealth of
knowledge and understanding of the major imaging manufacturers can
only benefit the Group, as we continue to expand our classroom to
the clinic ultrasound business."
The following details in relation to the appointment of Michele
Jeanine Lesieur (formerly Lucas), aged 61, are disclosed in
accordance with Schedule 2(g) of the AIM Rules:
Current directorships Directorships held within the
last five years
Intrasense SA Supersonic Imagine SA
------------------------------
Prodways Group SA SuperSonic Imagine Inc
------------------------------
SuperSonic Imagine Ltd
------------------------------
SuperSonic Imagine Gmbh
------------------------------
SuperSonic Imagine Srl
------------------------------
SuperSonic Imagine HK Ltd
------------------------------
SuperSonic Imagine (Shangai)
Medical Devices Co. Ltd
------------------------------
EOS Imaging SA
------------------------------
For further information, please contact:
Intelligent Ultrasound Group www. intelligentultrasound.com
plc
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Helen Jones, CFO
Cenkos Securities - Nominated Advisor Tel: +44 (0)20 7397 8900
and Broker
Giles Balleny / Max Gould (Corporate
Finance)
Dale Bellis / Julian Morse (Sales)
Walbrook PR Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com
Anna Dunphy / Paul McManus Mob: +44 (0)7876 741 001 / Mob: +44
(0)7980 541 893
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: IUG) develops artificial
intelligence-based clinical image analysis software tools for the
diagnostic medical ultrasound market and hi-fidelity virtual
reality simulators for the ultrasound training market. Based in
Cardiff in the UK and Atlanta in the US, the Group operates two
divisions:
Clinical AI Division
Focusses on developing deep learning-based algorithms to make
ultrasound machines smarter and more accessible. Products in the
market include :
ScanNav Assist
ScanNav Assist uses machine-learning based algorithms to
automatically identify and grade ultrasound images. GE Healthcare's
SonoLyst software on their Voluson SWIFT ultrasound machine
incorporates the ScanNav Assist AI technology and has received CE
and FDA regulatory approval. SonoLyst is the world's first fully
integrated AI tool that recognises the 20 views recommended by the
International Society of Ultrasound in Obstetrics and Gynaecology
mid-trimester practice guidelines for fetal imaging.
ScanNav Anatomy
ScanNav Anatomy PNB uses machine-learning based algorithms to
simplify ultrasound-guided needling by providing the user with
real-time AI-based anatomy highlighting software for a range of
medical procedures. ScanNav Anatomy has received CE approval and
has also been submitted for FDA regulatory approval.
ScanNav Anatomy PNB is therefore not available for sale in the
US or any other territory requiring government approval for this
type of product.
Simulation Division
Focusses on hi-fidelity ultrasound education and training
through simulation. Its main products are the ScanTrainer OBGYN
training simulator, the HeartWorks echocardiography training
simulator, the BodyWorks Eve Point of Care and Emergency Medicine
training simulator with Covid module and the new AI-based Anatomy
PNB training simulator. To date over 1,000 simulators have been
sold to over 600 medical institutions around the world.
www.intelligentultrasound.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAGPUQUBUPGGBC
(END) Dow Jones Newswires
September 15, 2021 02:00 ET (06:00 GMT)
Intelligent Ultrasound (LSE:MED)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
Intelligent Ultrasound (LSE:MED)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025
